| Financial Year |
March 31 2023 |
| Monetary Funds |
1,480,888,752.74 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
44,128,014.82 |
| Accounts Receivable |
1,009,233,571.06 |
| Advances to Suppliers |
23,660,081.60 |
| Other Receivables |
83,116,161.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
316,023,895.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,359,638.44 |
| Total Current Assets |
2,960,410,115.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
18,880,278.48 |
| Investment Properties |
-- |
| Fixed Assetes |
89,595,704.34 |
| Under-construction Projects |
152,320,500.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
204,135,910.95 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
40,118,803.29 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
555,491,252.77 |
| Total Assets |
3,515,901,367.80 |
| Short-Term Loans |
358,227,256.58 |
| Trading Financial liabilities |
-- |
| Notes Payable |
45,465,404.74 |
| Accounts Payable |
317,358,789.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,048,137.47 |
| Taxes Payable |
24,311,152.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,631,566.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,644,999.29 |
| Other Current Liabilities |
166,954.59 |
| Sub-Total of Current Liabilities |
775,255,487.61 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
14,734,799.62 |
| Deferred Income Tax Liabilities |
2,931,759.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
53,044,235.67 |
| Total Liabilities |
828,299,723.28 |
| Paid-In Capital(Or Share Stock) |
628,635,340.00 |
| Capital Surplus |
1,287,715,535.83 |
| Surplus Reserve |
95,780,505.20 |
| LESS:Treasury Stock |
6,334,333.50 |
| Undistributed Profits |
684,804,147.29 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,687,601,644.52 |
| Owner's Equity（Stockholder's Equity） |
2,687,601,644.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,515,901,367.80 |
